![Eric Shaff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Eric Shaff
Directeur/Membre du Conseil chez
SERES THERAPEUTICS, INC.
Fortune : 88 133 $ au 31/05/2026
Profil
Eric D.
Shaff is President, Chief Executive Officer & Director at PsiThera, Inc. since 2025.
Mr. Shaff is Director at Seres Therapeutics, Inc. since 2014.
Former roles include Independent Director at Sigilon Therapeutics, Inc. from 2017 to 2023, Principal at Pfizer Inc., Global Head-Rare Genetic Disease Finance at Genzyme Corp.
from 2004 to 2011, Vice President-Corporate Finance at Momenta Pharmaceuticals, Inc. from 2012 to 2014, and Senior Analyst at Broadview International LLC.
Education includes undergraduate studies at the University of Pennsylvania and an MBA from Johnson Graduate School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SERES THERAPEUTICS INC 0,12 % | 18/05/2026 | 12 040 ( 0,12 % ) | 88 133 $ | 31/05/2026 |
Postes actifs de Eric Shaff
| Sociétés | Poste | Début |
|---|---|---|
| SERES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 15/01/2019 |
Anciens postes connus de Eric Shaff
| Sociétés | Poste | Fin |
|---|---|---|
| SIGILON THERAPEUTICS, INC. | Directeur/Membre du Conseil | 11/08/2023 |
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/11/2014 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01/12/2011 |
| PFIZER INC. | Corporate Officer/Principal | - |
Broadview International LLC
 Broadview International LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Formation de Eric Shaff
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
66
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that discovers and develops novel biologic therapies for the treatment of rare immune-mediated diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Broadview International LLC
Broadview International LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Johnson Graduate School of Management
 Johnson Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Sigilon Therapeutics, Inc.
 Sigilon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops therapeutic treatments for chronic diseases | Health Technology |
